- Medicines
Polymer expertise in the fight against COVID-19
To boost vaccine production, Solvay, Ensinger and optek are safeguarding the value-added chain with precision components
More than 180 million people have become infected with the coronavirus SARS-CoV-2, which has already mutated multiple times. Effective vaccines have been developed in record time, but billions of vaccine doses are needed to defeat the pandemic. In order to expand production, sensor components – among other things – are urgently required. Sensor bodies – like those produced for optek by Ensinger from a high-performance plastic – enable quality control in the biopharmaceutical process.
“Our sensors detect, for example, the temperature, pH or protein concentration of the liquid”, explains Jürgen Danulat, Managing Director of optek, a company specialising in inline process control solutions. “The component with the measuring interfaces to the medium is complex and difficult to clean. Instead of flow-through assemblies of stainless steel, increased use is therefore being made of what are known as Single Use Cells (S.U.C.), which are disposed of after use. They minimise contamination risks, downtimes and costs associated with chemical cleaning, sterilisation and validation of the plants.”
High dedication to health
“Producing the sensor bodies from medical-grade polymer, glass and metal requires highly precise manufacturing technology. We have all of this expertise and all of these resources in-house”, says Dr. Roland Reber, Managing Director at Ensinger. “But we are dependent on good suppliers like Solvay. We have been fully supported with detailed technical expertise and provided with specific solutions regarding regulatory compliance throughout the whole process”.
“Our value-added services enhance our high-performance polymers and support biopharma processing trends. Radel® PPSU demonstrates how critically important material technologies are to this fast-changing and demanding sector. We take a highly proactive approach to material testing to support regulatory compliance needs”, said Jesal Chopra, Vice President – Healthcare, Environment, Consumer, & Construction, Materials Segment at Solvay.
Solvay produces the material polyphenylsulfone (PPSU), marketed as Radel®, in different colour shades. The biologically inert resin stands out for its high mechanical, chemical and thermal stability, and can be cleaned and sterilised using all established methods. At the Ensinger headquarters in Nufringen, the granular material is extruded into stock shapes. Further processing of the sheets and rods with the product name “TECASON P MT” takes place at the Cham site, Bavaria, the Ensinger Group’s largest branch factory.
Top quality – also in partnership
“Here we process engineering plastics into complex parts with extremely narrow tolerances for our customers,” says Fred Nass, who is in charge of Ensinger’s Machined Parts division with its approx. 150 employees. “Starting with stock shapes, we turn and shape the components with the aid of CNC processing centres, check the quality and after cleaning combine them into customised assemblies. We currently, in the cleanroom, configure and package around 100 versions of the sensor bodies for optek sensors as standard.”
Each processing step is precisely documented at Ensinger, and the quality continuously checked. “For us this is the same as with end customers from the medical and pharmaceutical fields, or from the aerospace sector: it’s all about premium quality and traceability along the entire value-added chain,” explains Fred Nass. “We benefit here from the fact that process-wise, Ensinger can be a one-stop shop – from raw materials delivery through to customer-specific packaging. We also have a very solid partnership with suppliers and customers. And that pays off in the long term – not just during the COVID pandemic.”
Ensinger GmbH
71154 Nufringen
Germany